# A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants

> **NCT04965389** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 17 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BMS-986177 Oral Solution
- **DRUG:** [14C]BMS-986177 Solution for Infusion
- **DRUG:** BMS-986177 Spray-dried Dispersion Capsules

## Key facts

- **NCT ID:** NCT04965389
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-16
- **Primary completion:** 2021-08-22
- **Final completion:** 2021-10-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2023-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04965389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04965389, "A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04965389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*